68Ga-FAPI-46 PET scan for head and neck cancer staging
Part of Cancer clinical trials.
This trial tests a new type of PET scan that uses a special tracer (68Ga-FAPI-46) to see if it can better show the extent of head and neck cancers before surgery. It may help doctors plan your treatment more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are generally healthy enough to do daily activities on your own (Karnofsky score 80% or higher)
- You have a confirmed head and neck cancer (squamous cell carcinoma) in the mouth, throat, or voice box
- The cancer has spread to at least one lymph node in your neck
- You are scheduled for surgery to remove lymph nodes from your neck (neck dissection)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental PET scan that may help doctors see how well standard radiation and chemotherapy are working for advanced head and neck cancer. It aims to improve treatment planning by tracking a specific molecule in the body.
This study tests a special PET/CT scan that may help doctors see the cancer more clearly in people with head and neck cancer, either at diagnosis or if it comes back.
This trial uses a special PET scan to look at diseases like cancer. It aims to see if this new imaging method can help doctors find or monitor disease better. This could be helpful for people with confirmed or suspected cancer or other conditions.
This study uses PET-CT scans (a type of imaging that highlights active cancer cells) in people with a specific kind of head and neck cancer. The goal is to see how well the first scan identifies tumors that should be checked again with a second scan, to better guide care with radiotherapy.
This trial tests a new type of PET/CT scan that uses a special tracer (called ⁶⁸Ga-FXX489) to help find and diagnose cancers. It is for people who are strongly suspected to have cancer and want to see if this new imaging method can help their doctors learn more about their disease.
This trial studies how well an imaging scan called 18F-FSPG PET shows whether head and neck or lung cancer responds to standard chemoradiotherapy. It may help doctors understand early signs of treatment success or failure.
Hear when a new Head and Neck Squamous Cell Carcinoma HNSCC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.